| Every month the ISN-ACT Team lists interesting new randomized controlled trials (RCTs) from around the world. |
| Highlights: |
| View the latest trials here. |
| A summary of the highlighted trial is now available in French, Mandarin, Russian, and Spanish. Support equal access to nephrology research: Become an ISN Member! |
Kidney International® Conventional cytotoxic chemotherapy–associated nephrotoxicity: consensus report of the 34th Acute... read more
As you continue to use ISN-Global Kidney Health Atlas (ISN-GKHA) data in your... read more
“If a drug improves creatinine but makes a patient too fatigued... read more
“We are truly a global journal: We do not just select [from]... read more
Why does chronic kidney disease of unknown origin (CKDu) remain so... read more
Kidney International® Tiny warriors, big impact: targeted immunotherapy in kidney diseases This review... read more
The WCN’26 interviews with abstract award winners offer a snapshot of... read more
Can lower-exposure tacrolimus plus everolimus improve outcomes in older kidney transplant... read more
What if better research approaches could help take the “unknown” out of chronic kidney disease... read more
NephJC has extended the conversation around WCN’26 late-breaking trials with expert commentary... read more
